Statistics for THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
Total visits
| views | |
|---|---|
| THOR is a targetable epigenetic biomarker with clinical implications in breast cancer | 18 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 1 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| 13148_2022_Article_1396.pdf(legacy) | 26 |
| 13148_2022_Article_1396.pdf | 11 |
Top country views
| views | |
|---|---|
| Portugal | 16 |
| United States | 5 |
Top city views
| views | |
|---|---|
| Faro | 1 |
| Lagos | 1 |
| Lisbon | 1 |